Colin Guy is a Senior Assay Development Manager in the BioPharmCMC division at Labcorp, leveraging his Ph. D. from Newcastle University. His expertise is centered on assay development, with a specific focus on the complexities of gene therapy.
He is at the forefront of exploring solutions for solid tumors, which make up 90% of adult cancers, by enhancing CAR T-cell therapies.
Colin Guy
Senior Assay Development Manager (BioPharmCMC) at Labcorp
Harrogate, England, United Kingdom
Overview
Topics They Care About
Gene & Cell Therapy
His career at Labcorp is focused on this domain, and he actively promotes webinars on advancements in CAR T-cell development for treating solid tumors.
Assay Development
This is his core professional function, having progressed from a senior scientist to a lead and now a senior manager overseeing these processes.
Oncology Innovation
He is involved in addressing significant challenges in cancer treatment by exploring methods to improve the metabolic fitness and persistence of cell therapies.
Media Appearances
Colin has no verified media appearances
Work History
3-2022
Senior Assay Development Manager (BioPharmCMC) at Labcorp
9-2019 - 5-2022
Lead Assay Development Scientist (BioPharmCMC) at Labcorp
2012 - 5-2022
Senior Assay Development Scientist (BioPharmCMC) at Covance
2010 - 2012
Senior Experimental Officer (BioPharmCMC) at Covance
2006 - 2010
Post-Doc Research Assistant at University of Aberdeen
Education
2002 - 2006
Doctor of Philosophy (Ph.D.) from Newcastle University
More Information
Social Presence :
Prographics :
Exp : 20
Location : Harrogate, England, United Kingdom
Job Level : Middle
Designation : Senior Assay Development Manager (BioPharmCMC) at Labcorp
